India, May 13 -- Shares of Merck KGaA were gaining around 8 percent in German trading after the science and technology major on Wednesday lifted its fiscal 2026 guidance and maintained mid-term view, despite weak first-quarter results.
Looking ahead for fiscal 2006, Merck now anticipates net sales between 20.4 billion euros and 21.4 billion euros, and EBITDA pre between 5.7 billion euros and 6.1 billion euros.
Merck previously projected net sales between 20.0 billion euros and 21.1 billion euros, and EBITDA pre between 5.5 billion euros and 6.0 billion euros.
Earnings per share pre is now projected between 7.50 euros and 8.20 euros, higher than previous estimate in a range of 7.10 euros to 8.00 euros.
The company said the revision prima...